Chemotherapy-induced hand foot syndrome: comparative efficacy and safety of pharmacological prophylaxis - systematic review and Bayesian network meta-analysis.
Mathan Kumar RamasubbuShampa MajiMilan PadhanRituparna MaitiDebasish HotaSaroj Kumar Das MajumdarAnand SrinivasanPublished in: BMJ supportive & palliative care (2022)
Only celecoxib (200 mg two times per day) showed significant prevention of the incidence of moderate to severe HFS. Pyridoxine (400 mg once daily) and urea cream (10%) have to be evaluated further in larger randomised trials.